227 related articles for article (PubMed ID: 24045135)
1. Scientific considerations for evaluating cancer bioassays conducted by the Ramazzini Institute.
Gift JS; Caldwell JC; Jinot J; Evans MV; Cote I; Vandenberg JJ
Environ Health Perspect; 2013; 121(11-12):1253-63. PubMed ID: 24045135
[TBL] [Abstract][Full Text] [Related]
2. Pathologists' perspective on the study design, analysis, and interpretation of proliferative lesions in a lifetime rodent carcinogenicity bioassay of sucralose.
Elmore SA; Rehg JE; Schoeb TR; Everitt JI; Bolon B
Food Chem Toxicol; 2024 Jun; 188():114524. PubMed ID: 38428799
[TBL] [Abstract][Full Text] [Related]
3. Hemolymphoreticular Neoplasias from the Ramazzini Institute Long-term Mice and Rat Studies on Aspartame.
Gnudi F; Panzacchi S; Tibaldi E; Iuliani M; Sgargi D; Bua L; Mandrioli D
Ann Glob Health; 2023; 89(1):43. PubMed ID: 37362827
[TBL] [Abstract][Full Text] [Related]
4. Pathologists' perspective on the study design, analysis, and interpretation of proliferative lesions in lifetime and prenatal rodent carcinogenicity bioassays of aspartame.
Elmore SA; Rehg JE; Schoeb TR; Everitt JI; Bolon B
Food Chem Toxicol; 2023 Jan; 171():113504. PubMed ID: 36414169
[TBL] [Abstract][Full Text] [Related]
5. Consideration of the variability in control tumor incidence data at the Ramazzini Institute in evaluating treatment-related effects following chemical exposure.
Gentry R; Greene T; Bartow H; Van Landingham C; Rodricks J; Clewell H
Crit Rev Toxicol; 2024 Mar; 54(3):153-173. PubMed ID: 38470145
[TBL] [Abstract][Full Text] [Related]
6. Chemicals studied and evaluated in long-term carcinogenesis bioassays by both the Ramazzini Foundation and the National Toxicology Program: in tribute to Cesare Maltoni and David Rall.
Huff J
Ann N Y Acad Sci; 2002 Dec; 982():208-30. PubMed ID: 12562639
[TBL] [Abstract][Full Text] [Related]
7. Long-term chemical carcinogenesis bioassays predict human cancer hazards. Issues, controversies, and uncertainties.
Huff J
Ann N Y Acad Sci; 1999; 895():56-79. PubMed ID: 10676409
[TBL] [Abstract][Full Text] [Related]
8. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
Gaylor DW
Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
[TBL] [Abstract][Full Text] [Related]
9. Identification of aspartame-induced haematopoietic and lymphoid tumours in rats after lifetime treatment.
Tibaldi E; Gnudi F; Panzacchi S; Mandrioli D; Vornoli A; Manservigi M; Sgargi D; Falcioni L; Bua L; Belpoggi F
Acta Histochem; 2020 Jul; 122(5):151548. PubMed ID: 32622430
[TBL] [Abstract][Full Text] [Related]
10. Pathology working group review of histopathologic specimens from three laboratory studies of diclofenac in trout.
Wolf JC; Ruehl-Fehlert C; Segner HE; Weber K; Hardisty JF
Aquat Toxicol; 2014 Jan; 146():127-36. PubMed ID: 24292026
[TBL] [Abstract][Full Text] [Related]
11. A review of mammalian carcinogenicity study design and potential effects of alternate test procedures on the safety evaluation of food ingredients.
Hayes AW; Dayan AD; Hall WC; Kodell RL; Williams GM; Waddell WD; Slesinski RS; Kruger CL
Regul Toxicol Pharmacol; 2011 Jun; 60(1 Suppl):S1-34. PubMed ID: 21094668
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of evidence for infection as a mode of action for induction of rat lymphoma.
Caldwell JC; Jinot J; DeVoney D; Gift JS
Environ Mol Mutagen; 2008 Mar; 49(2):155-64. PubMed ID: 18095346
[TBL] [Abstract][Full Text] [Related]
13. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
14. Mouse-specific carcinogens: an assessment of hazard and significance for validation of short-term carcinogenicity bioassays in transgenic mice.
Battershill JM; Fielder RJ
Hum Exp Toxicol; 1998 Apr; 17(4):193-205. PubMed ID: 9617631
[TBL] [Abstract][Full Text] [Related]
15. Effect of Dietary Restriction on Toxicology and Carcinogenesis Studies in F344/N Rats and B6C3F1 Mice.
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1997 Sep; 460():1-414. PubMed ID: 12587016
[TBL] [Abstract][Full Text] [Related]
16. Clinical Practice Guideline: Evaluation of the Neck Mass in Adults.
Pynnonen MA; Gillespie MB; Roman B; Rosenfeld RM; Tunkel DE; Bontempo L; Brook I; Chick DA; Colandrea M; Finestone SA; Fowler JC; Griffith CC; Henson Z; Levine C; Mehta V; Salama A; Scharpf J; Shatzkes DR; Stern WB; Youngerman JS; Corrigan MD
Otolaryngol Head Neck Surg; 2017 Sep; 157(2_suppl):S1-S30. PubMed ID: 28891406
[TBL] [Abstract][Full Text] [Related]
17. Comparing the accuracy of quantitative versus qualitative analyses of interim PET to prognosticate Hodgkin lymphoma: a systematic review protocol of diagnostic test accuracy.
Procházka V; Klugar M; Bachanova V; Klugarová J; Tučková D; Papajík T
BMJ Open; 2016 Aug; 6(8):e011729. PubMed ID: 27496236
[TBL] [Abstract][Full Text] [Related]
18. Ramazzini Foundation cancer program: history and major projects, life-span carcinogenicity bioassay design, chemicals studied, and results.
Soffritti M; Belpoggi F; Minardi F; Maltoni C
Ann N Y Acad Sci; 2002 Dec; 982():26-45. PubMed ID: 12562627
[TBL] [Abstract][Full Text] [Related]
19. A critical appraisal of the value of the mouse cancer bioassay in safety assessment.
Alden CL; Smith PF; Piper CE; Brej L
Toxicol Pathol; 1996; 24(6):722-5. PubMed ID: 8994300
[TBL] [Abstract][Full Text] [Related]
20. The role of narrow band imaging in early detection of head and neck cancer.
Tan NC; Herd MK; Brennan PA; Puxeddu R
Br J Oral Maxillofac Surg; 2012 Mar; 50(2):132-6. PubMed ID: 21232835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
